TITLE

TRANSARTERIAL CHEMOEMBOLIZATION IN THE INTERMEDIATE STAGE OF HEPATOCELLULAR CARCINOMA: SURVIVAL ANALYSIS

AUTHOR(S)
TAJIBAEV T. K.; MEDEUBEKOV U. SH.; CHORMANOV A. T.; SAGATOV I. Y.; KANIEV SH. A.; ISSAMATOV B. K.; BAIMAKHANOV B. B.
PUB. DATE
June 2019
SOURCE
New Armenian Medical Journal;Jun2019, Vol. 13 Issue 2, p111
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Hepatocellular carcinoma is the most common primary tumor pathology of the liver (> 85%), an aggressive course with an unfavorable prognosis. Objective: to elucidate the survival of various categories of patients with hepatocellular carcinoma in stage B hepatocellular carcinoma after transarterial chemoembolization. The study was conducted on the basis of the JSC "National Scientific Center of Surgery" named after A.N. Syzganov in the period 2013-2018. When analyzing survival, patients were divided into the following categories: gender, age, degree of liver function damage according to Child-Pugh scale, the presence of viral hepatitis B and C, and the level of alpha-fetoprotein. The average age of the patients was 60.4 years. The follow-up period was 2-64 months. The average length of stay of the patients studied in the hospital was 7.2 days. In patients older than 60 and 70 years, the 3-years and 5-years survival rates were 0%, the 1-year survival rate of the subjects studied in the group over 70 years of age was 14.3%. The one-year survival after transarterial chemoembolization in the total cohort left 42%, 2-years - 15% and 3-years - 5%, respectively. The survival rate among patients with cirrhosis of stage B on the Chile-Pugh scale was significantly lower than that of stage A patients (82% vs 56% for 6 months and 50% vs 31% for a year, respectively). In the group, a substantial increase of alphafetoprotein (>1000 IU/ml), the Kaplan-Meier survival curve showed a survival rate of 0% 18 months after the first transarterial chemoembolization. Transarterial chemoembolization showed good results in the group among women, and the life expectancy was higher in the middle-age group (50-59 years). Adult age, a high degree of liver dysfunction, as well as high alpha-fetoprotein values are additional factors that dramatically reduce the life expectancy of patients after transarterial chemoembolization with hepatocellular carcinoma hepatocellular carcinoma in stage B.
ACCESSION #
136850666

 

Related Articles

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics